-- 独立研究机构CFRA向提供了以下研究报告。CFRA分析师总结如下:GNRC第一季度业绩强劲,净销售额同比增长12%至10.6亿美元,调整后每股收益为1.80美元,远超市场预期的1.33美元。工商业(C&I)业务增长28%,主要得益于数据中心市场渗透率的加速提升,推动了营收增长,而住宅销售仅增长1%。我们认为工商业业务的出色表现验证了GNRC成功进军数据中心领域的决心,该公司已获得多家超大规模客户的最终供应商审批。管理层将全年销售额增长预期从15%上调至15%至18%之间,并将调整后EBITDA利润率预期从18.0%-19.0%上调至18.5%-19.5%。盈利能力显著提升,经调整后的 EBITDA 利润率增长 240 个基点至 18.3%,主要得益于运营效率的提高和有利的价格实现。收购 Allmand 和 Enercon 进一步拓展了非住宅业务组合。值得注意的是,业绩指引并未计入多年期超大规模协议可能带来的增量影响,我们认为这意味着业绩仍有增长空间。
Related Articles
Sysco Extends Q3 Momentum, Calms Restaurant Depot Concerns, UBS Says
Sysco's (SYY) momentum in fiscal Q3 remained intact as the company pushed back on concerns that its pending Jetro Restaurant Depot acquisition would require a costly overhaul, UBS Securities said Wednesday in a report.UBS said Sysco continued to post steady operational gains in the period, including its strongest US growth in case shipments to independent restaurants since Q3 2023. Questions around Restaurant Depot's condition may linger, though Sysco's third-party inspections of more than 160 stores helped ease investor concerns, the report said.International results also improved, and UBS expects that business to keep benefiting from supply-chain and private-label investments. Still, higher energy costs in Europe could pressure consumers if the Middle East conflict drags on, the report said.UBS maintained its buy rating on Sysco stock with a price target of $90.Price: $73.79, Change: $+0.42, Percent Change: +0.57%
Research Alert: CFRA Lowers Rating On Alexandria Real Estate Equities, Inc. To Sell From Hold
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We decrease our 12-month target by $29 to $35, a forward P/FFO of 6.1x our 2027 FFO estimate, a discount to ARE's one-year average (7.6x) due to negative re-leasing rates, planned asset sales, and a slowdown in leasing. We see 2027 revenue 17.8% lower than 2025 based on property sales/declining rents. We lower our 2026 FFO estimate by $0.26 to $6.27 and 2027's by $0.41 to $5.74. We now believe management has no visibility into re-leasing and occupancy trends even for 2H 2026 given the larger-than-expected decline in Q1 (-15.8% vs -5.2% in Q4 2026). While management believes AI will not replace physical labs, it could compress timelines and slow re-leasing in the near term. Management perceives the lifting of the 15% NIH limitation on reimbursement of indirect costs as a big win, but we do not anticipate this creating new demand in the near term. We also note that there is 1.5M sqft of lease expirations in 2027 that management now believes will have downtime negatively impacting 2027 by $97 million.
On Holding Likely to Post Q1 Sales Beat on Solid Trends, UBS Says
On Holding (ONON) is likely to post Q1 sales growth beat and raise its 2026 guidance on solid topline trends, UBS said in a Wednesday research report. The company is due to release Q1 results on May 12.The sentiment around the stock appears bearish amid the recent CEO change as well as high oil prices weighing much more on its margin guidance than expected, analysts wrote.Channel checks indicated that the company's Q1 digital trends were solid with total and unique global visits to its site rising 20% and 21%, respectively, while European Union spend likely grew 35%, according to the note.For Q1, UBS expects sales growth of 15.4%, but forex remains a material headwind, according to the note. For 2026, the brokerage said it expects the company to raise its sales growth guidance by 100 basis points.The brokerage maintained its buy rating on the stock and price target of $85 per share.Price: $34.95, Change: $-0.48, Percent Change: -1.35%